Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

This publication has 37 references indexed in Scilit:

• Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
  Vaccine, 2008
• Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia
  The Pediatric Infectious Disease Journal, 2007
• The burden of influenza in children
  Current Opinion in Infectious Diseases, 2007
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
  New England Journal of Medicine, 2007
• Complications of Influenza Infection in Children
  Pediatric Annals, 2000
• Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
  The Journal of Pediatrics, 2000
• Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold‐Adapted, Administered to Human Immunodeficiency Virus (HIV)–Infected and Non–HIV‐Infected Adults
  The Journal of Infectious Diseases, 2000
• Effect of Influenza Vaccination on Viral Replication and Immune Response in Persons Infected with Human Immunodeficiency Virus Receiving Potent Antiretroviral Therapy
  The Journal of Infectious Diseases, 2000
• Test‐Based Exact Confidence Intervals for the Difference of Two Binomial Proportions
  Biometrics, 1999
• Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
  Vaccine, 1999